SCHEMBL6284705

SCHEMBL6284705

Cc1ccc(Cc2ccc(O)c(Cc3cc(Cc4ccc(C)cc4C)ccc3O)c2)c(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.56
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
TP53 P04637 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 3/20 0.46
TRPA1 O75762 1/20 0.41
ALOX15 P16050 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
CYP3A4 P08684 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
HIF1A Q16665 2/20 0.40
SLC22A1 O15245 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSPD1 P10809 1/20 0.40
HSPA5 P11021 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26290273 0.83 AMY1A (0.83) AMY1AESR1ESR2TP53TDP1
SCHEMBL30485785 0.82 ESR1 (0.68) AMY1AESR1ESR2TP53TDP1
SCHEMBL1176702 0.82 ESR1 (0.68) AMY1AESR1ESR2TP53TDP1
SCHEMBL6573238 0.82 ALOX15 (0.58) AMY1AESR1ESR2TP53TDP1
SCHEMBL31294095 0.81 AMY1A (0.68) AMY1AESR1ESR2TP53TDP1
SCHEMBL7566966 0.80 ESR1 (0.48) ESR1ESR2TP53TDP1MAPT
SCHEMBL15248109 0.80 AMY1A (0.67) AMY1AESR1ESR2MAPTTRPA1
SCHEMBL10789460 0.80 AMY1A (0.53) AMY1ATP53TDP1MAPTSMN1; SMN2
SCHEMBL4624112 0.79 PYCR1 (0.42) TP53TDP1SMN1; SMN2CYP3A4IDO1
SCHEMBL50622 0.79 AMY1A (0.83) AMY1AESR1ESR2TP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6864381-B2 Process for preparing acyloxybenzenesulfonates CLARIANT GMBH (DE) 2005-03-08 US disclosed
US-20040198995-A1 Process for preparing acyloxybenzenesulfonates CLARIANT GMBH 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198995-A1 Process for preparing acyloxybenzenesulfonates TST, TYR, ACMSD AMY1A 2764/4885ESR1 2197/4885ESR2 3288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.